These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26852002)

  • 1. Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells.
    Carrett-Dias M; Almeida LK; Pereira JL; Almeida DV; Filgueira DM; Marins LF; Votto AP; Trindade GS
    Leuk Res; 2016 Mar; 42():13-20. PubMed ID: 26852002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
    Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
    Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT4 mutations in human erythroleukemic cells: implications for multiple drug resistance (MDR) phenotype.
    Oliveira BR; Figueiredo MA; Trindade GS; Marins LF
    Mol Cell Biochem; 2015 Feb; 400(1-2):41-50. PubMed ID: 25355160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between ABCB1 overexpression and COX2 and ALOX5 genes in human erythroleukemia cell lines.
    Salgado MTSF; Lopes AC; Fernandes E Silva E; Cardoso JQ; Vidal RS; Cavalcante-Silva LHA; Carvalho DCM; Machado KDS; Rodrigues-Mascarenhas S; Rumjanek VM; Votto APS
    Prostaglandins Other Lipid Mediat; 2021 Aug; 155():106553. PubMed ID: 33975019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
    Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
    Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
    Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
    Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
    Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
    Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia.
    Lettnin AP; Wagner EF; Salgado MTSF; Cañedo AD; Rumjanek VM; Trindade GS; Votto APS
    Gene; 2024 Jan; 892():147848. PubMed ID: 37774806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MDR and antitumoral action of acetylsalicylic acid on leukaemic cells.
    Carrett-Dias M; Votto AP; Filgueira Dde M; Almeida DV; Vallochi AL; D'Oca MG; Marins LF; Trindade GS
    Biosci Rep; 2011 Oct; 31(5):391-8. PubMed ID: 21361874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance phenotype: Relation between phenotype induction and its characteristics in erythroleukemia cells.
    Soares FS; Lettnin AP; Wagner EF; Mattozo FH; Carrett-Dias M; Rumjanek VMBD; Filgueira DMVB; de Souza Votto AP
    Cell Biol Int; 2019 Feb; 43(2):214-219. PubMed ID: 30597722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of reactive oxygen levels and gene expression in sensitive and resistant tumoral cells by C-phyocyanin.
    Fernandes E Silva E; Figueira FS; Lettnin AP; Salgado MTSF; Lopes AC; Rehbein F; Kalil SJ; Votto APS
    Mol Biol Rep; 2019 Feb; 46(1):1349-1356. PubMed ID: 30554313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to microcystins: a comparative study in human cell lines with and without multidrug resistance phenotype.
    de Souza Votto AP; Renon VP; Yunes JS; Rumjanek VM; Marques Capella MA; Neto VM; Sampaio de Freitas M; Alicia Geracitano L; Monserrat JM; Trindade GS
    Cell Biol Int; 2007 Nov; 31(11):1359-66. PubMed ID: 17611129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
    Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
    Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).
    Serrano A; Garcia A; Abril E; Garrido F; Ruiz-Cabello F
    Immunobiology; 1995 Nov; 194(4-5):449-56. PubMed ID: 8749237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in chemoresistant variants of three cell lines of different origin.
    Johnsson A; Vallon-Christensson J; Strand C; Litman T; Eriksen J
    Anticancer Res; 2005; 25(4):2661-8. PubMed ID: 16080509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of multidrug resistance related genes in leukemia by suppression subtractive hybridization].
    Zhu NX; Zheng S; Xu RZ; Gao RL; Shen JP; Yu RX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):14-7. PubMed ID: 12679003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of intracellular drug accumulation in MDR cell line K562r does not mean reversal of its drug resistance.
    Hu X; Chen WY
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):422-6. PubMed ID: 7717067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.